ISRCTN14165977进行中(未招募)未知
Relationship of antifungal exposure to emergence of Candida resistance in Intensive Care patients: a multi-site cohort study
St George’s University Hospitals NHS Foundation Trust0 个研究点目标入组 400 人开始时间: 2021年11月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Age =18 years
- •2. Currently receiving intravenous antibiotics
- •3. One or more of the following Candida risk factors:
- •3.1. Abdominal surgery in the last 4 weeks
- •3.2. Upper gastrointestinal/mediastinal perforation or surgery in the last 4 weeks
- •3.3. Liver failure
- •3.4. Haematological malignancy
- •3.5. Previous bone marrow or solid organ transplant
- •3.6. Neutropenia (neutrophils < 0.5*10e9/l)
- •3.7. Receipt of an immunosuppressive drug (including corticosteroids, chemotherapy, immune-modulators)
- •3.8. Total parenteral nutrition (TPN)
- •3.9. Renal replacement therapy
- •3.10. Extracorporeal membrane oxygenation (ECMO)
- •4. Suspected invasive candidiasis (added 25/08/2023)
排除标准
- •Expected ICU length of stay <48 h
研究者
相似试验
招募中
不适用
Risk factors and antifungal susceptibility of non-albicans candida in patient with candidemiaAge more than 18 yearsCandidemiacandidemiarisk factorsdrug susceptibilityantifungalTCTR20190501003Faculty of Medicine Siriraj Hospital150
已完成
不适用
Fungal allergy and domestic exposure to fungi in cystic fibrosis (Australian Cystic Fibrosis Research Trust 2004/052)Allergic Bronchopulmonary AspergillosisHuman Genetics and Inherited Disorders - Cystic fibrosisBlood - Other inflammatory or immune system disordersCystic FibrosisACTRN12605000156684Australian Cystic Fibrosis Research Trust 2004/05260
招募中
不适用
prevalence, epidemiology, antifungal susceptibility and factor associated with mortality in patients with candidemia in Srinagarind hospitalPrevalence ,antifungal ,candidemia ,mortalityTCTR20150605001faculty of medicine, khon kaen university20,332
进行中(未招募)
1 期
Empirical versus pre-emptive antifungal therapy of patients withhaematological malignanciesEmpirical versus pre-emptive (diagnosticdriven)antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label phase IIIstrategy study of the EORTC Infectious Diseases and Leukemia Groups.Invasive fungal infection in patients with hematological malignancies.MedDRA version: 14.1Level: LLTClassification code 10017544Term: FungemiaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-020814-27-NLEORTC556
尚未招募
2 期
Effect of local applicaton of bhurja ointment on dadru kustha .CTRI/2022/05/042512Ayurvedic and Unani Tibbia College and Hospital
